These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15769738)

  • 21. Expression of the RNA-binding protein IMP1 correlates with poor prognosis in ovarian carcinoma.
    Köbel M; Weidensdorfer D; Reinke C; Lederer M; Schmitt WD; Zeng K; Thomssen C; Hauptmann S; Hüttelmaier S
    Oncogene; 2007 Nov; 26(54):7584-9. PubMed ID: 17546046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CRD-BP shields c-myc and MDR-1 RNA from endonucleolytic attack by a mammalian endoribonuclease.
    Sparanese D; Lee CH
    Nucleic Acids Res; 2007; 35(4):1209-21. PubMed ID: 17264115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CRD-BP mediates stabilization of betaTrCP1 and c-myc mRNA in response to beta-catenin signalling.
    Noubissi FK; Elcheva I; Bhatia N; Shakoori A; Ougolkov A; Liu J; Minamoto T; Ross J; Fuchs SY; Spiegelman VS
    Nature; 2006 Jun; 441(7095):898-901. PubMed ID: 16778892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative expression of adhesion molecules on granulocyte colony-stimulating factor-mobilized peripheral blood, bone marrow, and cord blood CD34+ cells.
    Gigant C; Latger-Cannard V; Bensoussan D; Feugier P; Bordigoni P; Stoltz JF
    J Hematother Stem Cell Res; 2001 Dec; 10(6):807-14. PubMed ID: 11798507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of P16 cell cycle inhibitor in human cord blood CD34+ expanded cells following co-culture with bone marrow-derived mesenchymal stem cells.
    Oodi A; Noruzinia M; Habibi Roudkenar M; Nikougoftar M; Soltanpour MS; Khorshidfar M; Amirizadeh N
    Hematology; 2012 Nov; 17(6):334-40. PubMed ID: 22989929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. L-selectin expression enhances clonogenesis of CD34+ cord blood progenitors.
    Koenig JM; Baron S; Luo D; Benson NA; Deisseroth AB
    Pediatr Res; 1999 Jun; 45(6):867-70. PubMed ID: 10367780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Differential expression of a homing-related molecule repertoire among umbilical cord blood, mobilized peripheral blood and bone marrow-derived hematopoietic stem/progenitor cells].
    Zheng YZ; Zhang L; Wang HJ; Han ZC; Takahashi TA
    Zhonghua Xue Ye Xue Za Zhi; 2004 Dec; 25(12):736-9. PubMed ID: 15730718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IMP1 suppresses breast tumor growth and metastasis through the regulation of its target mRNAs.
    Wang G; Huang Z; Liu X; Huang W; Chen S; Zhou Y; Li D; Singer RH; Gu W
    Oncotarget; 2016 Mar; 7(13):15690-702. PubMed ID: 26910917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood-derived macrophage layers in the presence of hydrocortisone support myeloid progenitors in long-term cultures of CD34+ cord blood and bone marrow cells.
    Clausen J; Stockschläder M; Fehse N; Hassan HT; Gabl C; Zander AR
    Ann Hematol; 2000 Feb; 79(2):59-65. PubMed ID: 10741916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of the RNA-binding protein CRD-BP in brain and non-small cell lung tumors.
    Ioannidis P; Kottaridi C; Dimitriadis E; Courtis N; Mahaira L; Talieri M; Giannopoulos A; Iliadis K; Papaioannou D; Nasioulas G; Trangas T
    Cancer Lett; 2004 Jun; 209(2):245-50. PubMed ID: 15159028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CXCR-4 expression on bone marrow CD34+ cells prior to mobilization can predict mobilization adequacy in patients with hematologic malignancies.
    Dabusti M; Lanza F; Campioni D; Castagnari B; Tieghi A; Moretti S; Punturieri M; De Angeli C; Spanedda R; Ferrazzi E; Castoldi G
    J Hematother Stem Cell Res; 2003 Aug; 12(4):425-34. PubMed ID: 12965079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C-MYC and IGF-II mRNA-binding protein (CRD-BP/IMP-1) in benign and malignant mesenchymal tumors.
    Ioannidis P; Trangas T; Dimitriadis E; Samiotaki M; Kyriazoglou I; Tsiapalis CM; Kittas C; Agnantis N; Nielsen FC; Nielsen J; Christiansen J; Pandis N
    Int J Cancer; 2001 Nov; 94(4):480-4. PubMed ID: 11745432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The limited infectability by R5 HIV of CD34(+) cells from thymus, cord, and peripheral blood and bone marrow is explained by their ability to produce beta-chemokines.
    Majka M; Rozmyslowicz T; Ratajczak J; Dobrowsky A; Pietrzkowski Z; Gaulton GN; Janowska-Wieczorek A; Ratajczak MZ
    Exp Hematol; 2000 Dec; 28(12):1334-42. PubMed ID: 11146155
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppressive effects of TNF-alpha, TGF-beta1, and chemokines on megakaryocytic colony formation in CD34+ cells derived from umbilical cord blood compared with mobilized peripheral blood and bone marrow.
    Lu L; Wang LS; Cooper RJ; Liu HJ; Turner K; Weich N; Broxmeyer HE
    J Hematother Stem Cell Res; 2000 Apr; 9(2):195-204. PubMed ID: 10813532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Harvesting, characterization, and culture of CD34+ cells from human bone marrow, peripheral blood, and cord blood.
    Van Epps DE; Bender J; Lee W; Schilling M; Smith A; Smith S; Unverzagt K; Law P; Burgess J
    Blood Cells; 1994; 20(2-3):411-23. PubMed ID: 7538347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular insights into the coding region determinant-binding protein-RNA interaction through site-directed mutagenesis in the heterogeneous nuclear ribonucleoprotein-K-homology domains.
    Barnes M; van Rensburg G; Li WM; Mehmood K; Mackedenski S; Chan CM; King DT; Miller AL; Lee CH
    J Biol Chem; 2015 Jan; 290(1):625-39. PubMed ID: 25389298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences in megakaryocyte expansion potential between CD34(+) stem cells derived from cord blood, peripheral blood, and bone marrow from adults and children.
    van den Oudenrijn S; von dem Borne AE; de Haas M
    Exp Hematol; 2000 Sep; 28(9):1054-61. PubMed ID: 11008018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression and alteration of insulin-like growth factor II-messenger RNA in hepatoma tissues and peripheral blood of patients with hepatocellular carcinoma.
    Dong ZZ; Yao DF; Yao DB; Wu XH; Wu W; Qiu LW; Jiang DR; Zhu JH; Meng XY
    World J Gastroenterol; 2005 Aug; 11(30):4655-60. PubMed ID: 16094705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IMP1 promotes choriocarcinoma cell migration and invasion through the novel effectors RSK2 and PPME1.
    Hsieh YT; Chou MM; Chen HC; Tseng JJ
    Gynecol Oncol; 2013 Oct; 131(1):182-90. PubMed ID: 23911878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of the inhibitor-of-apoptosis family member survivin in normal cord blood and bone marrow CD34(+) cells by hematopoietic growth factors: implication of survivin expression in normal hematopoiesis.
    Fukuda S; Pelus LM
    Blood; 2001 Oct; 98(7):2091-100. PubMed ID: 11567995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.